Neurocrine Biosciences rises on FDA nod for CAH drug
Shares of Neurocrine (NASDAQ: NBIX ) Biosciences, Inc. (NASDAQ:NBIX) climbed 5.7% following the U.S. Food and Drug Administration’s approval of CRENESSITY, a new treatment for congenit...
Novo Nordisk stock rises following regulatory clearance of Catalent deal
Investing.com -- Shares of Novo Nordisk (NYSE: NVO ) climbed 2% today after the company announced the fulfillment of all regulatory closing conditions for its pending transaction with ...
SoftBank commits to $100 billion U.S. investment
In a significant move for the U.S. economy, President-elect Donald Trump and SoftBank (TYO: 9984 ) Group CEO Masayoshi Son announced a major investment plan on Monday. SoftBank will in...
